Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
"The coming trends in this category will be far more scrutiny from the FDA [U.S. Food and Drug and Administration] and other regulatory authorities, in an effort to protect the consumer," Ellis explained. "As we know, imported health care products enter the country essentially without regulatory review. Not only does this practice leave the consumer exposed to products that may be unsafe to use, it puts both the distributor and the importing supplier at risk in the event of a product liability claim. Over the next several years, we can expect this aspect of the business to change, to the benefit of the end-buyer."
0 Comments
View Comments
- Companies:
- Humphrey Line
- Oraline
- People:
- Mel Ellis
E
Melissa Busch
Author's page
Related Content
Comments